Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results marked t ...

Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.

Health-care companies rose sharply amid strong earnings.

Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...

U.S. stocks rose to a record as Wall Street regained some of the momentum that catapulted it to 57 all-time highs last year.

Elevance Health's quarterly dividend has been increased by 5% to $1.71 per share. The company's president and CEO, Gail K. Boudreaux, expressed the commitment to simplifying the healthcare experience ...

Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

For the quarter ended December 2024, Elevance Health (ELV) reported revenue of $44.99 billion, up 6% over the same period last year. EPS came in at $3.84, compared to $5.62 in the year-ago quarter.

As for his fresh call, the strategist now talks about a "monster vibe shift'" that has spread from those macro trades to equities. He notes downside risk hedging via bearish put options has given way ...